The Warner Babcock Institute for Green Chemistry and Elm Street Ventures Establish Occam Sciences to Develop and Commercialize Novel Forms of Existing Medicines
New Haven, CT and Wilmington, MA – The Warner Babcock Institute for Green Chemistry (WBI) and Elm Street Ventures (ESV) have announced today the formation of Occam Sciences in New Haven, CT to develop new forms of existing drugs with optimized bioavailabilty, including oral forms of medicines previously administrable only in a parenteral manner.
”We are delighted to join forces with WBI to develop new forms of already proven drugs that will offer important clinical benefits to patients”, said Rob Bettigole, Managing Partner of ESV. “Occam promises to be one of those rare start-ups that offers multiple bottom lines: better health for patients, improved environmental profile, profits for investors, and jobs for Connecticut and Massachusetts.”
WBI was cofounded in 2007 by Dr. John Warner, one of the founders of the field of Green Chemistry and co-author of Green Chemistry: Theory and Practice, a book that has revolutionized conventional wisdom across all industries touched by the chemical enterprise. Occam Sciences’ development efforts will utilize WBI’s proprietary non-covalent derivatization (NCD) technology to dial in selected physical properties for target drugs.
“We are pleased to have this opportunity to extend WBI’s NCD technology – already successfully commercialized in other industries – into the pharma realm”, said Joe Pont, CEO of WBI. “Our partnership with Elm Street Ventures is ideal given ESV’s deep network in both academic and industrial medical circles.”
Elm Street Ventures is a seed and early stage venture capital fund based in New Haven, Connecticut. An important part of ESV’s efforts is focused on creating and initially operating life sciences companies founded on intellectual property developed at Yale University and other research institutions in the New York City – New England region. Occam Sciences is ESV’s twelfth company. By providing management expertise and early stage capital, ESV catalyzes new company formation, working closely with scientists, engineers, and entrepreneurs to build significant technology companies. For more information, visit www.elmvc.com.
The Warner Babcock Institute for Green Chemistry provides innovation solutions and services across all markets and industries, from idea creation through commercial product optimization. WBI is committed to its clients, to society, and to the environment to create technologies and processes that are functional, cost-effective, and environmentally benign. For more information, please visit www.warnerbabcock.com.